Artwork

Content provided by KGK Science. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGK Science or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

FDA's Human Foods Program and New Dietary Ingredient (NDI) Guidance

35:59
 
Share
 

Manage episode 493332214 series 3649261
Content provided by KGK Science. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGK Science or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode of the Orange Pill Podcast, we unpack the FDA’s newly released 2025 Human Foods Programme guidance agenda and the persistent challenges stalling finalization of the long-awaited New Dietary Ingredient (NDI) guidance. From the implications of regulatory orders that demand a "10-for-1" rule, to open questions around bioidentical molecules and the fate of the self-affirmed GRAS pathway, we explore what’s at stake for dietary supplement stakeholders.

We also dive into how industry can play a role—through public comments, strategic feedback, and thoughtful engagement—to influence the next phase of supplement oversight in a changing regulatory landscape.

  continue reading

38 episodes

Artwork
iconShare
 
Manage episode 493332214 series 3649261
Content provided by KGK Science. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGK Science or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode of the Orange Pill Podcast, we unpack the FDA’s newly released 2025 Human Foods Programme guidance agenda and the persistent challenges stalling finalization of the long-awaited New Dietary Ingredient (NDI) guidance. From the implications of regulatory orders that demand a "10-for-1" rule, to open questions around bioidentical molecules and the fate of the self-affirmed GRAS pathway, we explore what’s at stake for dietary supplement stakeholders.

We also dive into how industry can play a role—through public comments, strategic feedback, and thoughtful engagement—to influence the next phase of supplement oversight in a changing regulatory landscape.

  continue reading

38 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play